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ABSTRACT: The in vivo biocompatibility of dextrin hydrogels obtained by
polymerization of dextrin-hydroxyethylmethacrylate (dextrin-HEMA) and dex-
trin-vinyl acrylate (dextrin-VA) are reported in this work. The histological
analysis of subcutaneous implants of these hydrogels, featuring inflammatory
and reabsorption events, were carried out over a 16-week period in mice. The
dextrin-HEMA hydrogel was quickly and completely degraded and reabsorbed,
whereas the dextrin-VA degradation occurred slowly and a thin fibrous capsule
surrounded the nondegradable hydrogel. The dextrin-HEMA was degraded after
16 weeks with only mild inflammation and a few detectable foamy macrophages
around the implant. These events were followed by complete resorption and no
sign of capsule formation or fibrosis associated to the implants. The results
indicate that the dextrin hydrogels are biocompatible because no toxicity on the
tissues surrounding the implants was found. It may be speculated that a
controlled degradation rate of the hydrogels may be obtained by grafting dextrin
to HEMA and VA in different proportions.
KEY WORDS: hydrogels, dextrin, biocompatibility, degradability, HEMA,
dextran-HEMA, dextran-vinyl acetate, in vivo assay.
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INTRODUCTION
Hydrogels are water-swollen polymeric materials, with a stable3D structure that provide scaffolds for tissue engineering and
replacement, wound dressings, and drug delivery systems, among other
applications [1]. They are also used to encapsulate cells that produce
therapeutic agents, such as growth factors, to be released in the
surrounding tissues [2–5]. Hydrogels must meet several strict require-
ments to be eligible for biomedical applications, such as biocompatibility,
together with the nontoxicity of the leachable and degradation products.
Therefore, a comprehensive characterization of the degradation pro-
cesses and the biological effects of the by-products are crucial in
determining the long-term success of a hydrogel application [6–9].
Natural polymers, modified using specific strategies, are an important
source of hydrogel biomaterials [10–13]. We developed hydrogels made
from dextrin, a polysaccharide obtained by partial hydrolysis of starch,
composed of (1! 4) linked D-glucose residues [6,7]. It was found that
the dextrin-based hydrogels have distinct degradation profiles, in vitro,
depending on the acrylate ester used to functionalize the polysaccharide:
dextrin-vinyl acrylate (VA) originates a nondegradable hydrogel, while
polymerized dextrin-hydroxyethylmethacrylate (HEMA) is a degradable
one [14]. Moreover, the degree of substitution (DS) of the polymer was
shown to influence the degradation profile.
Although similar to previously developed dextran-VA and dextran-
HEMA materials [10], the use of dextrin hydrogels represent, in our
view, a better choice for biomedical applications. Dextrin is already used
in clinical treatments, such as end-stage renal failure patients,
peritoneal dialysis solution, and as a carrier for the anticancer agents
[3,15–17] but is relatively unexploited in the biomaterials field. Dextrin
presents excellent biocompatibility, nonimmunogenicity, and in vivo
degradability by a-amylases, yielding maltose and isomaltose. The
molecular weight of dextrin is appropriate to ensure renal elimination,
thus excludes the threat of progressive accumulation after repeated
administration [2,17–19]. Due to the low molecular weight and readily
degradation to glucose by the amylases present in the human fluids, it is
expected to be completely metabolized or removed by renal filtration.
Biodegradability and resorption are highly desirable for tissue
engineering and for other biomedical applications where a temporary
use of a medical device is envisaged to avoid further surgery to extract it.
Therefore, the degradation of the hydrogel used, under a set of
conditions, must be thoroughly characterized to determine the
suitability of the material for given bioapplications. In this work, the
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in vivo biocompatibility and degradability of dextrin-HEMA and dextrin-
VA are described.
MATERIAL AND METHODS
Reagents
Dextrin-Koldex 60 starch was a generous gift from Tate & Lyle
(Decatur, IL, USA). All chemicals used in the preparation of the
hydrogels, including VA, 2-HEMA, N,N,N0,N0-tetramethylenethylene-
diamine (TEMED), and ammonium persulfate (APS) were laboratory
grade from Sigma-Aldrich, St. Louis, MO, USA.
Animals
The in vivo biocompatibility studies were performed using male
BALB/c mice (8 weeks old) purchased from Charles River (Barcelona,
Spain). The animals were kept at the Institute Abel Salazar animal
facilities during the experiments. All procedures involving the mice were
performed according to the European Convention for the Protection of
Vertebrate Animals used for Experimental and Scientific Purposes (ETS
123) and 86/609/EEC Directive and Portuguese Rules (DL 129/92).
Preparation of Dextrin-based Hydrogels
The functionalization of the dextrin with VA and HEMA was achieved
as described by Carvalho et al. [2,14]. Dextrin-VA and dextrin-HEMA
monomers were synthesized in DMSO with specific amounts of dextrin
and VA or HEMA monomers. The DS was determined by proton nuclear
resonance spectroscopy (1H-NMR) in D2O as previously described [2,14].
Hydrogels with different DS were prepared by radical polymerization of
dextrin-VA (or dextrin-HEMA). For implantation, 300mg of dextrin-VA
(DS¼ 20 or 70) were dissolved in 1mL of phosphate buffered saline
(PBS); 30 mL of this solution was cast into the circular discs (5mm in
diameter and 5mm thick). After polymerization, by adding 3mL of
TEMED (13.3%, v/v) and 3 mL APS (80%, w/v) to the dextrin solution,
the discs were transferred to an Eppendorf vial with PBS buffer and
sterilized (1218C, 1 atm, 20min). The dextrin-HEMA hydrogel with DS
20 was prepared using two concentrations, 300 and 150mg/mL,
respectively.
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MALDI-TOF Analysis
The molecular weight of the dextrin used in the hydrogel preparation
was evaluated by matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry (MALDI-TOF), using a 4700 MALDI-TOF
Proteomics Analyzer (Applied Biosystems) and a matrix of 2, 5-
dihydroxybenzoic acid.
Cryo-SEM Analysis
The cryo-scanning electron microscopy (cryo-SEM) analysis of the
polymerized hydrogels was performed using a JEOL JSM 6301F/Oxford
INCA Energy 350/Gatan Alto 2500, 15 kV, WD 15mm.
Subcutaneous Implantation
The hydrogels were surgically implanted subcutaneously in the backs
of the mice with each mouse receiving two implants. The mice were
anesthetized by an intramuscular injection of a ketamine (Imalgene
1000, Material) and Bompun 2% (Bayer Healthcare) mixture, at a 50
and 10mg/kg dose, respectively. The hair was removed and two small
incisions were made in the skin as bilateral subcutaneous pockets along
the backbone and the hydrogel discs implanted and the incisions closed
with stitches. The control animals received no implants. For each type of
implant, two animals were used for each postimplantation period
analyzed.
Histological Analysis
Aspects of the wound and the presence of edema were observed before
removing the implants. Two animals, each one containing two implants,
were sacrificed sequentially at 1, 2, 4, 8, and 16 weeks after
implantation. The implantations sites were completely excised for
histological analysis. Samples were fixed in 10% neutral buffered
formalin for 24 h and paraffin embedded. Sections 4-mm thick were
obtained and used for hematoxylin and eosin (H&E), Schiff’s periodic
acid (PAS), and Masson’s trichrome stains. Slides were examined under
a light microscope (Nikon E600), and photographs were obtained using
a digital camera (Nikon DS-5M).
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RESULTS
Previously, we have described the structure, rheology, and in vitro
biocompatibility of dextrin hydrogels [2,14,19] and further character-
ization is provided in this work. The dextrin MALDI-TOF mass
spectrum, the chemical structures of dextrin-VA, dextrin-HEMA, and
the corresponding hydrogels are presented in Figure 1. MALDI-TOF
analysis is not quantitative, the lower molecular weight oligomers
producing a stronger signal. The dextrin mass spectrum data supports
the gas chromatography methylation analysis that the polymer has very
low molecular weight and is highly polydisperse. Peaks corresponding to
a degree of polymerization up to 15 are detected, confirming the
previously determined average degree of polymerization of 13. This is a
Figure 1. Dextrin MALDI-TOF mass spectra and chemical structure of dextrin
substituted with VA or HEMA and its structure following polymerization.
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relevant finding since the dextrin low molecular weight fractions are
pertinent to the efficient clearance of the hydrogel degradation
products.
In both cases, the polymer was functionalized by transesterification
with acrylate esters to yield water-soluble functionalized dextrin-VA
or dextrin-HEMA. Gelation was achieved by polymerizing the double
bonds in the presence of TEMED and APS to form cross-links. Shown
in Figure 1 is the schematic representation of the dextrin substituted
with VA and HEMA as well as their structures after polymerization,
based on the dextran-HEMA and dextran-VA structures previously
reported [20–22]. The ester bonds obtained behaved differently; the VA
cross-links were resistant to hydrolysis, while HEMA were hydrolysable
in an enzyme-free system (shown elsewhere [14]). The structural
patterns of the hydrogels, obtained by cryo-SEM analysis, are shown in
Figure 2. The dextrin-VA and dextrin-HEMA hydrogels exhibited
distinct porosities; the former was more compact and less porous for
Dextrin-VA
5µm
30µm
10
00
 x
50
00
 x
Dextrin-HEMA
Figure 2. Cryo-SEM analysis of polymerized hydrogels: dextrin-VA and dextrin-HEMA
(DS 20%, 300mg/mL). Analysis performed at 15kV; amplification: 5000 and 1000.
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the same DS (20%) and concentration (300mg/mL). The hydrogels also
presented distinct mechanical properties differences that were noticed
by visual evaluation [14].
Dextrin-VA is a Nondegradable Hydrogel In Vivo
To evaluate the biocompatibility of dextrin-based hydrogels and its
degradation behavior in vivo, BALB/c mice were implanted subcuta-
neously with dextrin-VA or dextrin-HEMA hydrogels. The implanted
tissue was removed at specific times and histological analyses were
carried out. After 1 week postimplantation, a mild to moderate subacute
focal inflammatory response was observed at the surgical sites on both
the control and implanted animals. Both groups showed marked
vascular congestion and interstitial edema, with moderate infiltration
of neutrophils, a few macrophages and lymphocytes, together with
proliferation of fibroblastic and endothelial cells (Figure 3). This was
interpreted as a reaction to surgical trauma rather than to the implants
since both the treated and control animals responded similarly.
From 2 to 4 weeks postimplantation, the vascular phenomena
decreased. Macrophages progressively became more predominant within
the cellular infiltrate and concentrated around the implanted material.
Figure 3. DS 20 dextrin-VA implant, 1 week postimplantation. The implant (*) is intact
(PAS, bar¼50mm).
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Some smaller hydrogel particles were observed to be surrounded by
foamy macrophages, which showed moderate amounts of intracytoplas-
mic PAS-positive hydrogel material. This was more evident with the DS
20 hydrogels since these were softer and easily fragmented during
surgery.
By week 16 postimplantation, the inflammatory reaction had
subsided, with only a thin macrophagic ring surrounding the implants.
Although small hydrogel fragments seemed to be amenable to
phagocytosis, the main bulk of the implants showed no signs of
resorption (Figure 4(a) and (b)). Using Masson’s trichrome stain, thin
fibrous capsules were observed at 16 weeks postimplantation
around both DS 20 (30.78 1.79mm) and DS 70 (34.78 2.64 mm)
implants (Figure 4(c)).
Dextrin-HEMA is a Degradable Hydrogel In Vivo
After 1 week postimplantation, the control animals showed identical
changes to those described for dextrin-VA, while the dextrin-HEMA
implanted animals presented a moderate to intense subacute inflam-
matory response, focused around the implanted material. There was
moderate vascular congestion and mild interstitial edema, with
moderate to intense, mixed infiltration of neutrophils and less
macrophages. Both 150 and 300mg/mL implants showed mild signs of
resorption, with a few foamy macrophages exhibiting intracytoplasmic
PAS-positive material (Figure 5).
From week 2 to 4, the number of neutrophils progressively decreased
and foamy macrophages became largely predominant. At week 4, there
were no signs of extracellular 150mg/mL material left, but variably sized
(a) (b) (c)
Figure 4. DS 20 dextrin-VA implant, 16 weeks postimplantation. The implant (*) is
generally intact. (a) Note a ring of macrophages around the implant and a few scattered
fragments (arrows) in its vicinity (H&E, bar¼ 200mm); (b) Small DS 20 dextrin-VA
fragments surrounded by numerous macrophages showing small amounts of intracyto-
plasmic PAS-positive material (PAS, bar¼50 mm); (c) The implant (*) is surrounded by a
fibrous capsule (arrows), showing five consecutive measurements (Masson’s trichrome
stain, bar¼20mm).
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accumulations of foamy macrophages laden with PAS-positive material
were present, forming a subdermal band (Figure 6(a) and (b)). Fragments
of the 300mg/mL implants were still partially visible (Figure 6(c)). By
week 8 postimplantation, both groups already showed complete implant
resorption and neither group presented any signs of capsule formation or,
indeed, fibrosis associated with the implants (data not shown).
Figure 5. Dextrin-HEMA 300mg/mL implant, 1 week postimplantation. The implant
is generally intact and surrounded by macrophages with PAS-positive material
(PAS, bar¼10mm).
(a) (b) (c)
Figure 6. Dextrin-HEMA (a, b) 150mg/mL, and (c) 300mg/mL implant, 4 weeks
postimplantation. (a) There are no visible extracellular fragments of the implant.
Numerous macrophages containing abundant intracellular PAS-positive material form a
subdermal band located at the implantation site (PAS, bar¼ 200mm); (b) Variably
abundant, intracytoplasmic, globular, PAS-positive material is present in macrophages
(PAS, bar¼ 10mm); (c) Large, extracellular implant fragments remain in the deep dermis,
surrounded by a thick macrophagic ring (PAS, bar¼ 200mm).
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DISCUSSION
The results obtained with dextrin-VA hydrogels indicate its apparent
nondegradability in vivo, irrespective of the DS of the polymer used.
This hydrogel was rendered degradable in vitro by the incorporation of
amylase, which proved to be effective in modulating the gel degradation
and release of entrapped molecules [18]. However, in vivo insignificant
degradation was observed for the dextrin-VA hydrogels, as described for
dextran-MA (methacrylated) hydrogels [10]. In the vicinity of the
implanted DS 20 hydrogel, some macrophages, positively stained with
PAS, were observed; however, the bulk material remained intact. This
suggests that, while the smaller hydrogel fragments (probably from
mechanical fragmentation during implantation) were being reabsorbed,
the hydrogel was basically nondegradable. Similar findings were
described for dextran-MA hydrogels [10,23].
Due to its high stiffness, the dextrin-VA DS 70 hydrogel implants were
always damaged during the process of inclusion for histological analysis.
Nevertheless, fibrous capsules were identified at the implant site. By
week 16, after implantation, only a thin macrophagic ring surrounding
the implants was observed together with the fibrous capsule. Since the
material did not induce detectable necrosis, immunotoxicity, or damage
to muscle tissue, the dextrin-VA hydrogels presented biocompatible
behavior in vivo [24].
The dextrin-HEMA was previously shown to be degradable in vitro, in
PBS, with rate depending on the polymer DS [14]. Similar to dextrin-
VA, the dextrin-HEMA hydrogels presented biocompatible behavior.
The histological analysis after 1 week postimplantation, inflammatory
responses due to implantation, macrophages were observed indicating
resorption, which increased during the time course of the experiment,
with complete degradation at week 4 postimplantation, for the 150
mg/mL hydrogels. The 300mg/mL hydrogel required more time for
complete resorption; thus, the degradation rate is controllable by
appropriate selection of the polymer concentration.
CONCLUSIONS
The in vivo biocompatibility of dextrin hydrogels obtained by
polymerization of dextrin-HEMA and dextrin-VA were evaluated. Both
presented biocompatible behavior, as none induced necrosis, immuno-
toxicity, or damage to muscle tissue. Thus, both can be used in different
applications and their degradation profile can be controlled by selecting
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the polymer DS and its concentration. Based on these results, dextrin
hydrogels with mixed reticulation chemistry, such as HEMA or VA in
different proportions, may be used to fine-tune degradation rates.
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